Skip to content
Disclosery

Deep Track Capital, LP

Follow

13F filer, CIK 1856083, GREENWICH, CT

Deep Track Capital, LP reported $6,870,469,447 across 67 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 40.09% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001856083-26-000004

Period
2026-06-30
Reported value
$6.87B
Holdings
67
Top 10 weight
40.09%
New
19
Sold out
15

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ALNYnew+825,000$248M
MANEadded+1,500,000$184M
COAGnew+3,602,093$132M
BMRNadded+2,157,481$123M
GHRSnew+3,333,334$89.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
APLSexited-4,532,374-$182M
CNTAexited-3,158,041-$125M
AXSMreduced-400,000-$97.9M
IMVTreduced-2,185,820-$84.2M
BBIOexited-841,445-$62.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001856083-26-000004, largest first. % of portfolio is the value over $6,788,059,447, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 6,000,560 shares; 2024Q4: 6,419,566 shares; 2025Q1: 5,443,721 shares; 2025Q2: 4,250,000 shares; 2025Q3: 4,154,086 shares; 2025Q4: 2,800,000 shares; 2026Q1: 3,338,241 shares; 2026Q2: 3,393,312 shares 3,393,312$509M7.5%+55,071Timeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 4,347,464 shares; 2024Q4: 6,000,000 shares; 2025Q1: 9,500,000 shares; 2025Q2: 9,500,000 shares; 2025Q3: 9,728,845 shares; 2025Q4: 11,526,971 shares; 2026Q1: 11,526,971 shares; 2026Q2: 9,341,151 shares 9,341,151$360M5.3%-2,185,820Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,220,508 shares; 2024Q4: 2,800,000 shares; 2025Q1: 4,100,000 shares; 2025Q2: 5,133,917 shares; 2025Q3: 4,215,811 shares; 2025Q4: 4,111,782 shares; 2026Q1: 4,279,848 shares; 2026Q2: 4,740,072 shares 4,740,072$254M3.75%+460,224Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 750,000 shares; 2025Q2: 2,150,000 shares; 2025Q3: 3,000,000 shares; 2025Q4: 4,000,000 shares; 2026Q1: 4,300,000 shares; 2026Q2: 4,300,000 shares 4,300,000$250M3.68%0Timeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 825,000 shares 825,000$248M3.66%newTimeline
MANEVERADERMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 500,000 shares; 2026Q2: 2,000,000 shares 2,000,000$246M3.62%+1,500,000Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,484,266 shares; 2025Q2: 1,750,000 shares; 2025Q3: 3,000,000 shares; 2025Q4: 3,004,034 shares; 2026Q1: 3,600,000 shares; 2026Q2: 3,666,768 shares 3,666,768$231M3.4%+66,768Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,376,324 shares; 2026Q2: 1,783,322 shares 1,783,322$220M3.24%+406,998Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,500,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,000,000 shares; 2026Q1: 3,590,323 shares; 2026Q2: 4,000,000 shares 4,000,000$210M3.09%+409,677Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 12,721,460 shares; 2024Q4: 12,836,282 shares; 2025Q1: 14,294,420 shares; 2025Q2: 14,294,420 shares; 2025Q3: 11,932,137 shares; 2025Q4: 8,070,414 shares; 2026Q1: 19,686,282 shares; 2026Q2: 19,686,282 shares 19,686,282$193M2.85%0Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 24,856 shares; 2025Q4: 2,300,000 shares; 2026Q1: 1,150,000 shares; 2026Q2: 3,307,481 shares 3,307,481$189M2.79%+2,157,481Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,868,104 shares; 2024Q4: 3,000,000 shares; 2025Q1: 5,500,000 shares; 2025Q2: 6,064,910 shares; 2025Q3: 6,057,024 shares; 2025Q4: 7,036,455 shares; 2026Q1: 6,345,244 shares; 2026Q2: 7,736,455 shares 7,736,455$188M2.76%+1,391,211Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,235,187 shares; 2024Q4: 750,000 shares; 2025Q1: 1,444,709 shares; 2025Q2: 1,918,798 shares; 2025Q3: 2,654,781 shares; 2025Q4: 2,161,510 shares; 2026Q1: 2,034,203 shares; 2026Q2: 1,926,000 shares 1,926,000$183M2.7%-108,203Timeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,772,595 shares; 2026Q2: 6,348,558 shares 6,348,558$179M2.63%-424,037Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,200,000 shares; 2024Q4: 1,933,928 shares; 2025Q1: 4,564,207 shares; 2025Q2: 4,891,544 shares; 2025Q3: 3,808,144 shares; 2025Q4: 1,700,000 shares; 2026Q1: 1,950,000 shares; 2026Q2: 2,200,000 shares 2,200,000$174M2.57%+250,000Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 8,859,648 shares; 2025Q2: 8,831,007 shares; 2025Q3: 7,859,648 shares; 2025Q4: 7,334,323 shares; 2026Q1: 12,161,496 shares; 2026Q2: 12,161,496 shares 12,161,496$172M2.54%0Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,821,135 shares; 2026Q1: 4,106,067 shares; 2026Q2: 4,000,000 shares 4,000,000$172M2.53%-106,067Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 857,219 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 801,371 shares; 2025Q3: 900,000 shares; 2025Q4: 1,150,000 shares; 2026Q1: 1,100,000 shares; 2026Q2: 700,000 shares 700,000$171M2.52%-400,000Timeline
GMABGENMAB A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 2,000,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 481,267 shares; 2025Q4: not reported; 2026Q1: 3,663,250 shares; 2026Q2: 5,650,000 shares 5,650,000$155M2.29%+1,986,750Timeline
MLTXMOONLAKE IMMUNOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,610,071 shares; 2026Q1: 6,408,863 shares; 2026Q2: 6,999,025 shares 6,999,025$136M2.01%+590,162Timeline
COAGHEMAB THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,602,093 shares 3,602,093$132M1.95%newTimeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,454,562 shares; 2025Q4: 2,454,562 shares; 2026Q1: 2,750,000 shares; 2026Q2: 4,200,000 shares 4,200,000$131M1.93%+1,450,000Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,000,000 shares; 2026Q2: 2,750,000 shares 2,750,000$129M1.91%-250,000Timeline
GRALGRAIL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,022,797 shares; 2026Q1: 1,722,797 shares; 2026Q2: 1,834,944 shares 1,834,944$125M1.85%+112,147Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 796,852 shares; 2024Q4: 2,000,000 shares; 2025Q1: 2,000,000 shares; 2025Q2: 2,426,657 shares; 2025Q3: 2,426,657 shares; 2025Q4: 2,614,004 shares; 2026Q1: 4,062,500 shares; 2026Q2: 4,100,000 shares 4,100,000$122M1.79%+37,500Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 3,269,126 shares; 2025Q2: 3,948,910 shares; 2025Q3: 3,948,910 shares; 2025Q4: 4,246,440 shares; 2026Q1: 3,477,562 shares; 2026Q2: 3,732,569 shares 3,732,569$111M1.64%+255,007Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 1,540,132 shares; 2025Q1: 2,000,000 shares; 2025Q2: 2,000,000 shares; 2025Q3: 2,000,000 shares; 2025Q4: 1,900,738 shares; 2026Q1: 1,283,979 shares; 2026Q2: 2,939,151 shares 2,939,151$109M1.61%+1,655,172Timeline
LBRXLB PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,352,804 shares; 2025Q4: 3,352,804 shares; 2026Q1: 3,352,804 shares; 2026Q2: 3,352,804 shares 3,352,804$109M1.6%0Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,018,935 shares; 2024Q4: 3,018,935 shares; 2025Q1: 3,018,935 shares; 2025Q2: 2,188,592 shares; 2025Q3: 3,150,000 shares; 2025Q4: 3,249,790 shares; 2026Q1: 2,757,569 shares; 2026Q2: 1,732,569 shares 1,732,569$95.6M1.41%-1,025,000Timeline
GHRSGH RESEARCH PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,000,000 shares; 2025Q2: 2,000,000 shares; 2025Q3: 1,250,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,333,334 shares 3,333,334$89.6M1.32%newTimeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 453,102 shares; 2026Q1: 1,000,000 shares; 2026Q2: 2,000,000 shares 2,000,000$77.4M1.14%+1,000,000Timeline
ATAIATAIBECKLEY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 12,000,000 shares; 2026Q2: 14,417,442 shares 14,417,442$76M1.12%+2,417,442Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 123,616 shares 123,616$67M0.99%newTimeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 967,000 shares; 2024Q4: 867,000 shares; 2025Q1: 859,876 shares; 2025Q2: 567,103 shares; 2025Q3: 144,600 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,610,000 shares 3,610,000$66.7M0.98%newTimeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,750,945 shares; 2024Q4: 4,522,741 shares; 2025Q1: 5,380,449 shares; 2025Q2: 5,380,449 shares; 2025Q3: 5,380,449 shares; 2025Q4: 2,524,833 shares; 2026Q1: 1,393,944 shares; 2026Q2: 3,592,740 shares 3,592,740$66M0.97%+2,198,796Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 629,906 shares; 2024Q4: 2,500,000 shares; 2025Q1: 3,073,853 shares; 2025Q2: 3,650,000 shares; 2025Q3: 4,300,000 shares; 2025Q4: 3,336,998 shares; 2026Q1: 1,374,320 shares; 2026Q2: 700,000 shares 700,000$59.6M0.88%-674,320Timeline
ALTALTIMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 19,250,000 shares 19,250,000$58.5M0.86%newTimeline
PSNLPERSONALIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,000,000 shares; 2026Q2: 4,000,000 shares 4,000,000$53.6M0.79%+1,000,000Timeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 9,345,000 shares; 2026Q2: 9,345,000 shares 9,345,000$49.4M0.73%0Timeline
CRMDCORMEDIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 500,000 shares; 2025Q4: 5,274,076 shares; 2026Q1: 6,274,076 shares; 2026Q2: 6,274,076 shares 6,274,076$49.3M0.73%0Timeline
WGSGENEDX HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 700,000 shares 700,000$48.1M0.71%newTimeline
HROWHARROW INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 969,000 shares 969,000$41.2M0.61%newTimeline
CRVSCORVUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,491,539 shares; 2026Q2: 2,491,939 shares 2,491,939$37.2M0.55%+400Timeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,565,062 shares; 2026Q2: 3,565,062 shares 3,565,062$35.6M0.52%0Timeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 315,765 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 820,765 shares; 2026Q2: 1,000,000 shares 1,000,000$34.3M0.51%+179,235Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,282,000 shares; 2024Q4: 2,000,000 shares; 2025Q1: 2,000,000 shares; 2025Q2: not reported; 2025Q3: 2,000,000 shares; 2025Q4: 2,650,000 shares; 2026Q1: 2,000,000 shares; 2026Q2: 1,500,000 shares 1,500,000$33.3M0.49%-500,000Timeline
IMMXIMMIX BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,775,000 shares 2,775,000$28.6M0.42%newTimeline
XFORX4 PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,122,484 shares; 2025Q4: 5,013,661 shares; 2026Q1: 6,339,535 shares; 2026Q2: 5,878,757 shares 5,878,757$27.5M0.4%-460,778Timeline
STTKSHATTUCK LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,706,734 shares 3,706,734$25.7M0.38%newTimeline
MNKDMANNKIND CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,000,000 shares 6,000,000$25.6M0.38%newTimeline
IPSCCENTURY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 9,487,745 shares; 2026Q2: 9,462,645 shares 9,462,645$23.2M0.34%-25,100Timeline
GENBGENERATE BIOMEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,333,815 shares 1,333,815$22.5M0.33%newTimeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,740,850 shares; 2026Q1: 5,740,850 shares; 2026Q2: 5,740,850 shares 5,740,850$21.9M0.32%0Timeline
KURAKURA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,963,505 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,643,542 shares; 2026Q2: 1,978,565 shares 1,978,565$21.7M0.32%-664,977Timeline
ENTAENANTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,956,867 shares; 2026Q1: 1,956,867 shares; 2026Q2: 1,444,167 shares 1,444,167$21.1M0.31%-512,700Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 300,000 shares 300,000$20.9M0.31%newTimeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 4,000,000 shares; 2024Q4: 3,442,833 shares; 2025Q1: 3,442,833 shares; 2025Q2: 3,442,833 shares; 2025Q3: 3,470,172 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,500,000 shares 1,500,000$18.8M0.28%newTimeline
KLRAKAILERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 700,000 shares 700,000$15.4M0.23%newTimeline
KARDKARDIGAN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 600,000 shares 600,000$14.3M0.21%newTimeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 225,000 shares 225,000$11.4M0.17%newTimeline
PMNPROMIS NEUROSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 835,655 shares; 2026Q2: 835,655 shares 835,655$11M0.16%0Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 519,376 shares; 2025Q1: 1,411,402 shares; 2025Q2: 1,800,000 shares; 2025Q3: 1,800,000 shares; 2025Q4: 2,003,978 shares; 2026Q1: 1,931,884 shares; 2026Q2: 311,218 shares 311,218$9.88M0.15%-1,620,666Timeline
XNCRXENCOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 800,000 shares; 2024Q4: 500,000 shares; 2025Q1: 549,439 shares; 2025Q2: 549,439 shares; 2025Q3: 549,439 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 593,551 shares 593,551$9.56M0.14%newTimeline
CNTXCONTEXT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,419,355 shares; 2024Q4: 7,419,355 shares; 2025Q1: 7,419,355 shares; 2025Q2: 7,419,355 shares; 2025Q3: 7,419,355 shares; 2025Q4: 7,419,355 shares; 2026Q1: 7,419,355 shares; 2026Q2: 7,419,355 shares 7,419,355$4.11M0.06%0Timeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 490,000 shares; 2026Q1: 1,222,453 shares; 2026Q2: 800,000 shares 800,000$3.02M0.04%-422,453Timeline
ALGSALIGOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 244,110 shares; 2024Q4: 244,110 shares; 2025Q1: 444,110 shares; 2025Q2: 444,110 shares; 2025Q3: 444,110 shares; 2025Q4: 444,110 shares; 2026Q1: 444,110 shares; 2026Q2: 444,110 shares 444,110$2.56M0.04%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
GMABGENMAB A/S Ordinary Shares, nominal value DKK 1 per sharecall3,000,000$82.4Mnew

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
XBISPDR SERIES TRUST10,000,000$1.28Bput
APLSAPELLIS PHARMACEUTICALS INC4,532,374$182Mshares
CNTACENTESSA PHARMACEUTICALS PLC3,158,041$125Mshares
BBIOBRIDGEBIO PHARMA INC841,445$62.5Mshares
TERNTERNS PHARMACEUTICALS INC1,073,877$56.6Mshares
GERNGERON CORP31,720,278$47.3Mshares
ANIPANI PHARMACEUTICALS INC600,000$46.1Mshares
SLNOSOLENO THERAPEUTICS INC1,078,710$36.1Mshares
ENGNENGENE HOLDINGS INC4,377,572$29.8Mshares
APGEAPOGEE THERAPEUTICS INC285,000$24Mshares
JANXJANUX THERAPEUTICS INC1,187,290$16.5Mshares
CBIOCRESCENT BIOPHARMA INC.453,686$8.33Mshares
LRMRLARIMAR THERAPEUTICS INC1,500,000$6.75Mshares
HELPCYBIN INC1,313,137$6.3Mshares
BLLNBILLIONTOONE INC50,000$3.95Mshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001856083-26-000004 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001856083-26-000004 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001856083-26-000003 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001856083-26-000001 Quarter ended 2025-12-312026-02-13acceptance time not in the bulk data set
13F-HR 0001856083-25-000006 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001856083-25-000004 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001856083-25-000002 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001856083-25-000001 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001856083-24-000007 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001856083-24-000003 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001856083-24-000002 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0001856083-24-000001 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0001856083-23-000005 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR/A 0001856083-23-000004 Quarter ended 2023-06-302023-09-06acceptance time not in the bulk data set
13F-HR 0001856083-23-000003 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001856083-23-000002 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0001856083-23-000001 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001856083-22-000012 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001856083-22-000011 Quarter ended 2022-06-302022-08-12acceptance time not in the bulk data set
13F-HR 0001856083-22-000010 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0001856083-22-000007 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set